Regarding their phenotypes, CD86+ cDC1 were more frequently detected than CD86+ cDC2 in tumor tissue, with 44.44 ± 10.62% and 7.72 ± 4.84%, respectively (Figure 2D, Supplementary Figure 7). The gene discussed is CD86; the disease is neoplasm.